DTDavid H. Truong

David H. Truong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David H. Truong has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Dane K. Wukich

    Department of Orthopaedic Surgery University of Texas Southwestern Medical Center Dallas Texas USA

    3 shared publications
  • Lawrence A. Lavery

    Department of Plastic Surgery University of Texas Southwestern Medical Center Dallas Texas USA

    3 shared publications
  • Peter A. Crisologo

    Department of Plastic Surgery University of Texas Southwestern Medical Center Dallas Texas USA

    3 shared publications
  • Javier La Fontaine

    Professor, Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX

    2 shared publications
  • Lawrence A. Lavery

    Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA

    2 shared publications
  • Matthew J. Johnson

    Dallas, TX, Cincinnati, OH

    2 shared publications

Latest Publications

  • Open Access

    Update of biomarkers to diagnose diabetic foot osteomyelitis: A meta‐analysis and systematic review

    by Elizabeth A. Ansert, Arthur N. Tarricone, Tyler L. Coye, Peter A. Crisologo, David Truong, Mehmet A. Suludere, Lawrence A. Lavery

    The aim of this study was to evaluate the diagnostic characteristics of biomarker for diabetic foot osteomyelitis (DFO). We searched PubMed, Scopus, Embase and Medline for studies who report serological markers and DFO before December 2022. Studies must include at least one of the following diagnostic parameters for biomarkers: area under the curve, sensitivities, specificities, positive predictive value, negative predictive value. Two authors evaluated quality using the Quality Assessment of Diagnostic Accuracy Studies tool. We included 19 papers. In this systematic review, there were 2854 subjects with 2134 (74.8%) of those patients being included in the meta‐analysis. The most common biomarkers were erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP) and procalcitonin (PCT). A meta‐analysis was then performed where data were evaluated with Forrest plots and receiver operating characteristic curves. The pooled sensitivity and specificity were 0.72 and 0.75 for PCT, 0.72 and 0.76 for CRP and 0.70 and 0.77 for ESR. Pooled area under the curves for ESR, CRP and PCT were 0.83, 0.77 and 0.71, respectfully. Average diagnostic odds ratios were 16.1 (range 3.6–55.4), 14.3 (range 2.7–48.7) and 6.7 (range 3.6–10.4) for ESR, CRP and PCT, respectfully. None of the biomarkers we evaluated could be rated as ‘outstanding’ to diagnose osteomyelitis. Based on the areas under the curve, ESR is an ‘excellent’ biomarker to detect osteomyelitis, and CRP and PCT are ‘acceptable’ biomarkers to diagnose osteomyelitis. Diagnostic odds ratios indicate that ESR, CRP and PCT are ‘good’ or ‘very good’ tools to identify osteomyelitis.


  • Differences in Radiotherapy-Treated Members with Cancer during COVID-19 Pandemic Using Nationwide Claim Data

    by A.T. Berman, C. Schmidt, D. Truong, S. Reddy, E. Avalos-Reyes, H. Yeon, R. Brito, D. Verbrugge, K. Johnson

  • Open Access

    Success of transmetatarsal amputation for limb salvage in patients with peripheral artery disease

    by David H. Truong, Anthony K. Ngoo, Shirling Tsai, Anna K. Yang, Dane K. Wukich, Lawrence A. Lavery

    Limb salvage is a difficult path for patients to travel as there is no guarantee of the outcome, often the major factor is perfusion. For patients who underwent transmetatarsal amputation (TMA), success rate is crucial as the next option is most likely a major amputation. We performed a 10 years (2010–2020) retrospective review of patients that underwent a TMA and had an angiogram or computed tomography angiography (CTA) perioperatively at the Dallas VA Medical Center. Failure after TMA was defined as a patient requiring a proximal amputation within 1 year. There were 125 TMAs performed between 2010 and 2020 at the institution. Forty‐four (35.2%) patients had an angiogram/CTA peri‐operative and met the inclusion criteria. Seventeen subjects (38.6%) had a higher level of amputation. Of the 17 failures, 2 (11.8%) patients had no patent vessel runoff to the foot, 9 (52.9%) had one vessel, 4 (23.5%) had two vessels, and 2 (11.8%) had three vessels runoff. One vessel runoff to the foot yielded a high rate of poor outcomes (56.3%) defined as a higher level of amputation. Two or more vessels runoff to the foot had over 75% success of limb salvage with a TMA.


  • Open Access

    Meta-Analysis: Outcomes of Surgical and Medical Management of Diabetic Foot Osteomyelitis

    by David H Truong, Roger Bedimo, Matthew Malone, Dane K Wukich, Orhan K Oz, Amanda L Killeen, Lawrence A Lavery

    To evaluate clinical outcomes in the published literature on medical and surgical management of diabetic foot osteomyelitis (DFO). A PubMed and Google Scholar search of articles relating to DFO was performed over the dates of January 1931 to January 2020. Articles that involved Charcot arthropathy, case reports, small case series, review articles, commentaries, non-human studies, and non-English articles were excluded. QUADAS-2 was used to rate the bias of each study. A meta-analysis was performed using random-effects and inverse variance methods. The search yielded 1,192 articles. After reviewing and removal of articles that did not meet inclusion criteria, 28 articles remained. Eighteen articles related to the medical management of DFO and 13 articles related to surgical management. Three articles looked at a combination of medical and surgical management and were included in both groups. Heterogeneity was evaluated using Cochran’s Q, I2, τ2 and τ. The average success rate for medical treatment was 68.2% (range 17.0 to 97.3%), and for surgical and medical treatment was 85.7% (range 65.0 to 98.8%). There were significant inconsistencies in accounting for peripheral arterial disease and peripheral neuropathy. There was significant heterogeneity in outcomes between studies. However, there was a high rate of successful treatment and a wide range between patients with medical treatment and combined surgical and medical treatment. Additional properly designed prospective studies with gold-standard references for diagnosing OM are needed to help determine whether medical management of DFO can be successful without surgical intervention.


  • 218-OR: Does Antibiotic Treatment before Bone Biopsy Affect the Identification of Bacterial Pathogens from Bone Culture?

    by Lawrence A. Lavery, Easton C. Ryan, David H. Truong, Matthew J. Johnson, Javier LA Fontaine, Peter A. Crisologo

    Our aim was to evaluate the effect of antibiotic exposure on bacterial pathogen yield in patients with diabetic foot osteomyelitis. In a retrospective cohort study, we evaluated 142 patients admitted to the hospital with diabetic foot osteomyelitis which confirmed by histologic evaluation. Histologic criteria for osteomyelitis included the presence of an inflammatory response, bone necrosis, and/or bone fragmentation. We compared bacterial pathogens in patients that received antibiotics before bone culture (n=114) and patients that did not receive antibiotics (n=28), as well as bacterial yield based on the duration of antibiotic exposure. We used the chi square test to compare antibiotic exposure and culture yield. There was not a significant difference in culture yield in patients that received antibiotics (77.9%) and patients that did not (85.7%, p=0.58). There was no difference in patients that received antibiotics for ≥4 days (n=56, 71.4%), 1-3 days (n=58, 84.5%) and no antibiotics (85.7%, p=0.15). In conclusion, the results of bacterial recovery were similar in patients regardless of the length of antibiotic treatment. Antibiotic exposure did not change the bacterial yield, the type of bacteria or the number of bacteria. In patients with suspected diabetic foot osteomyelitis, there is no evidence to support withholding antibiotics prior to obtaining a bone biopsy. Disclosure: L.A. Lavery: Advisory Panel; Self; Acelity, Bayer AG. Consultant; Self; Boehringer Ingelheim International GmbH. Research Support; Self; AstraZeneca, Cardinal Health, EO2 Concepts, Integra LifeSciences, MedImmune, Smith & Nephew. E.C. Ryan: None. D.H. Truong: None. M.J. Johnson: None. J. La Fontaine: None. P.A. Crisologo: None.


  • Open Access

    Nonhealing Wounds with Verrucous Presentation in the Neuropathic Patient: A Report of Two Cases

    by David H. Truong, Ellianne M. Nasser

    Verrucous skin lesions on the feet of diabetic patients in conjunction with a neuropathic foot ulcer is an uncommon incident. Currently, there are approximately 20 reported cases in the literature. Herein we report two cases of verrucous lesions superimposing a chronic diabetic ulcer. Patients failed several conservative treatments, and several biopsies were performed with inconclusive results, suggesting possible underlying verrucous carcinoma. Given the possibility of underlying malignancy, both patients were treated with wide excision, and both were negative for malignancy, thus confirming verrucous skin lesions on the feet in diabetic neuropathy. We also summarize the current literature on verrucous skin lesions on the feet in diabetic neuropathy.


  • Outcomes of Foot Infections Secondary to Puncture Injuries in Patients With and Without Diabetes

    by David H. Truong, Matthew J. Johnson, Peter A. Crisologo, Dane K. Wukich, Kavitha Bhavan, Javier La Fontaine, Lawrence A. Lavery


  • Erbium: Yttrium Aluminum Garnet Laser Accelerates Healing in Indolent Diabetic Foot Ulcers

    by Matthew J. Johnson, Peter A. Crisologo, David H. Truong, Dane K. Wukich, Orhan K. Oz, Javier La Fontaine, Lawrence A. Lavery


  • Non‐uraemic calciphylaxis successfully treated with pamidronate infusion

    by David H. Truong, Marcus M. Riedhammer, Kathya Zinszer

    Calciphylaxis is a rare and potentially fatal disease that affects the subcutaneous layer of the skin. It is a calcific vasculopathy induced by a systemic process that causes occlusion of small blood vessels. The mortality rate for individuals diagnosed with calciphylaxis is estimated between 52% and 81% with sepsis being the leading cause of death. Uraemic calciphylaxis and its known effective treatments are well documented in the literature. Unfortunately, there is no known effective treatment for non‐uraemic calciphylaxis. Most of the current treatments for non‐uraemic calciphylaxis are derived from uraemic calciphylaxis treatment protocols. We report a case of a 75‐year‐old female with calciphylaxis on the right lower extremity who was successfully treated with four pamidronate infusions in addition to local wound care. This case represents a non‐uraemic calciphylaxis wound successfully treated with pamidronate infusions and standard wound care, and suggests that IV pamidronate can be an effective treatment option.